Reducing homocysteine levels does not prevent stroke recurrenceBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7435.307 (Published 05 February 2004) Cite this as: BMJ 2004;328:307
- Scott Gottlieb
- New York
Among patients with a previous stroke, reducing levels of the amino acid homocysteine in the blood with high dose vitamin therapy does not reduce the risk of recurrent stroke.
Previous studies have shown an association between raised levels of total homocysteine and the risk of stroke and heart disease (Stroke 2004;35:169-74). Folic acid, pyridoxine (vitamin B-6), and cobalamin (vitamin B-12) are known to reduce plasma homocysteine levels, but the effectiveness of homocysteine lowering therapy to reduce the risk of stroke has not been confirmed by randomised trials.
Dr James Toole of Wake …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial